Molecular targeting therapies for neuroblastoma: Progress and challenges
Molecular targeting therapies for neuroblastoma: Progress and challenges is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Molecular targeting therapies for neuroblastoma: Progress and challenges have?
Molecular targeting therapies for neuroblastoma: Progress and challenges has 397 citations in the OpenAlex counts ScholarIQ stores.
When was Molecular targeting therapies for neuroblastoma: Progress and challenges published?
Molecular targeting therapies for neuroblastoma: Progress and challenges has 2020 year in the ScholarIQ index.
What is the open-access status of Molecular targeting therapies for neuroblastoma: Progress and challenges?
Molecular targeting therapies for neuroblastoma: Progress and challenges has hybrid oa status in the ScholarIQ index.
What is the DOI of Molecular targeting therapies for neuroblastoma: Progress and challenges?
The DOI for Molecular targeting therapies for neuroblastoma: Progress and challenges is on the source record.
What is the PMID of Molecular targeting therapies for neuroblastoma: Progress and challenges?
The PMID for Molecular targeting therapies for neuroblastoma: Progress and challenges is on the source record.
What is the OpenAlex record for Molecular targeting therapies for neuroblastoma: Progress and challenges?
The OpenAlex for Molecular targeting therapies for neuroblastoma: Progress and challenges is on the source record.